Skip to main content

Advertisement

SpringerLink
Log in

Pathological features of highly invasive glioma stem cells in a mouse xenograft model

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

Glioma stem cells (GSCs) may be a source of tumor progression and recurrence after multimodal therapy, because of their high invasive potential. The purpose of this study was to compare the invasive and migratory properties of GSCs and non-GSCs and examine the distribution of these cells in a mouse xenograft model. Three GSC lines, G144, Y02, and Y10, cultured from human glioblastoma, were used in the study. Matrigel-invasion assays of infiltration and time-lapse studies of migration were performed for comparison of the GSCs with the corresponding differentiated non-GSC lines. Cells were also transplanted into mouse brain and the different distribution of GSCs and non-GSCs was examined in the tumor xenograft model. All 3 GSC lines had greater invasion and migration ability than the corresponding non-GSCs. In vivo, GSCs infiltrated more widely than non-GSCs and reached the contralateral hemisphere via the corpus callosum in the early stage of tumorigenesis. GSCs also primarily penetrated the subventricular zone (SVZ). GSCs have high invasive potential and tend to be present in the outer tumor bulk and infiltrate the contralateral hemisphere via the corpus callosum, in addition to penetrating the SVZ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  PubMed  CAS  Google Scholar 

  2. Molina JR, Hayashi Y, Stephens C, Georgescu MM (2010) Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia 12:453–463

    PubMed Central  PubMed  CAS  Google Scholar 

  3. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828

    PubMed  CAS  Google Scholar 

  4. Velpula KK, Rehman AA, Chelluboina B, Dasari VR, Gondi CS, Rao JS, Veeravalli KK (2012) Glioma stem cell invasion through regulation of the interconnected ERK, integrin alpha6 and N-cadherin signaling pathway. Cell Signal 24:2076–2084

    Article  PubMed  CAS  Google Scholar 

  5. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760

    Article  PubMed  CAS  Google Scholar 

  6. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M, Squire JA, Smith A, Dirks P (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4:568–580

    Article  PubMed  CAS  Google Scholar 

  7. Chua C, Zaiden N, Chong KH, See SJ, Wong MC, Ang BT, Tang C (2008) Characterization of a side population of astrocytoma cells in response to temozolomide. J Neurosurg 109:856–866

    Article  PubMed  CAS  Google Scholar 

  8. Ulasov IV, Nandi S, Dey M, Sonabend AM, Lesniak MS (2011) Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Mol Med 17:103–112

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  9. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, Holland EC (2009) PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4:226–235

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  10. Hide T, Takezaki T, Nakamura H, Kuratsu J, Kondo T (2008) Brain tumor stem cells as research and treatment targets. Brain Tumor Pathol 25:67–72

    Article  PubMed  Google Scholar 

  11. Dong J, Huang Q (2011) Targeting glioma stem cells: enough to terminate gliomagenesis? Chin Med J (Engl) 124:2756–2763

    CAS  Google Scholar 

  12. Huang Z, Cheng L, Guryanova OA, Wu Q, Bao S (2010) Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting. Protein Cell 1:638–655

    Article  PubMed  CAS  Google Scholar 

  13. Inoue A, Takahashi H, Harada H, Kohno S, Ohue S, Kobayashi K, Yano H, Tanaka J, Ohnishi T (2010) Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity. Int J Oncol 37:1121–1131

    PubMed  CAS  Google Scholar 

  14. Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JN, Bao S (2011) Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun 406:643–648

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432:396–401

    Article  PubMed  CAS  Google Scholar 

  16. Son MJ, Woolard K, Nam DH, Lee J, Fine HA (2009) SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4:440–452

    Article  PubMed  CAS  Google Scholar 

  17. Ward RJ, Lee L, Graham K, Satkunendran T, Yoshikawa K, Ling E, Harper L, Austin R, Nieuwenhuis E, Clarke ID, Hui CC, Dirks PB (2009) Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. Cancer Res 69:4682–4690

    Article  PubMed  CAS  Google Scholar 

  18. Dell’Albani P (2008) Stem cell markers in gliomas. Neurochem Res 33:2407–2415

    Article  PubMed  CAS  Google Scholar 

  19. Dimov I, Tasic-Dimov D, Conic I, Stefanovic V (2011) Glioblastoma multiforme stem cells. ScientificWorldJournal 11:930–958

    Article  PubMed  CAS  Google Scholar 

  20. Fatoo A, Nanaszko MJ, Allen BB, Mok CL, Bukanova EN, Beyene R, Moliterno JA, Boockvar JA (2011) Understanding the role of tumor stem cells in glioblastoma multiforme: a review article. J Neurooncol 103:397–408

    Article  PubMed  CAS  Google Scholar 

  21. Lathia JD, Gallagher J, Myers JT, Li M, Vasanji A, McLendon RE, Hjelmeland AB, Huang AY, Rich JN (2011) Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells. PLoS ONE 6:e24807

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  22. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, Modrusan Z, Nacu S, Guerrero S, Edgar KA, Wallin JJ, Lamszus K, Westphal M, Heim S, James CD, VandenBerg SR, Costello JF, Moorefield S, Cowdrey CJ, Prados M, Phillips HS (2010) A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17:362–375

    Article  PubMed  CAS  Google Scholar 

  23. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109

    Article  PubMed Central  PubMed  Google Scholar 

  24. Tavazoie M, Van der Veken L, Silva-Vargas V, Louissaint M, Colonna L, Zaidi B, Garcia-Verdugo JM, Doetsch F (2008) A specialized vascular niche for adult neural stem cells. Cell Stem Cell 3:279–288

    Article  PubMed  CAS  Google Scholar 

  25. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, Gilbertson RJ (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69–82

    Article  PubMed  CAS  Google Scholar 

  26. Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, Hjelmeland AB, Rich JN (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15:501–513

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  27. Seidel S, Garvalov BK, Wirta V, von Stechow L, Schanzer A, Meletis K, Wolter M, Sommerlad D, Henze AT, Nister M, Reifenberger G, Lundeberg J, Frisen J, Acker T (2010) A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain 133:983–995

    Article  PubMed  Google Scholar 

  28. Binello E, Germano IM (2011) Targeting glioma stem cells: a novel framework for brain tumors. Cancer Sci 102:1958–1966

    Article  PubMed  CAS  Google Scholar 

  29. Munoz DM, Guha A (2011) Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas. Oncotarget 2:590–598

    PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Sonia Labatt Brain Tumor Research Center, Toronto, Canada. We are grateful to Peter B. Dirks for providing GS cell lines.

Author information

Authors and Affiliations

  1. Department of Neurosurgery and Clinical Neuroscience, Yamaguchi University School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, Japan

    Hirokazu Sadahiro, Koichi Yoshikawa, Makoto Ideguchi, Koji Kajiwara & Michiyasu Suzuki

  2. Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan

    Aya Ishii & Eiji Ikeda

  3. Department of Organ Anatomy, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan

    Yuji Owada & Yuki Yasumoto

Authors
  1. Hirokazu Sadahiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koichi Yoshikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Makoto Ideguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Koji Kajiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aya Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eiji Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuji Owada
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yuki Yasumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michiyasu Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hirokazu Sadahiro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sadahiro, H., Yoshikawa, K., Ideguchi, M. et al. Pathological features of highly invasive glioma stem cells in a mouse xenograft model. Brain Tumor Pathol 31, 77–84 (2014). https://doi.org/10.1007/s10014-013-0149-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-013-0149-x

Keywords

Search

Navigation